marginally significantp = 0.045
None of the 17 patients who were administered an ivTA (0%) developed pCME, whereas 16 of the 81 patients who were not administered an ivTA (19.8%) developed pCME; this difference was marginally significant (Chi-square 4.01, p = 0.045).